Eupraxia Pharmaceuticals ( ($TSE:EPRX) ) has shared an update. On April 24, 2025, Eupraxia Pharmaceuticals announced its participation in several ...

Eupraxia’s CEO, Dr. James Helliwell, will be presenting on May 5th, 2025, at 3:30pm ET at the Bloom Burton & Co. Healthcare Investor Conference being held at the Metro Toronto Convention Centre, and ...

Gastroesophageal reflux disease (GERD), also known as gastro oesophageal reflux disease, is more than just the occasional ...

White and Hispanic US veterans with a diagnosis of ultrashort Barrett esophagus had an increased risk of persistent Barrett esophagus.

In a US study, patients with severe eosinophilic esophagitis (EoE) by Index of Severity for EoE had poor responses to topical corticosteroid therapy.

Celldex’s cash runway extends into 2027, but potential delays or hurdles could necessitate earlier fundraising, exerting ...

NS-229 is an investigational selective Janus kinase 1 inhibitor designed to prevent tissue damage caused by EGPA by suppressing immune cell activation.

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...

In this blog, we’ll break down the top reasons to seek a GERD specialist, how they can help, and what you can expect during your visit.

Eosinophilic esophagitis (EoE) is a long-term immune system disease that causes inflammation to your esophagus, the tube that connects your mouth and stomach. Scientists think this may happen when ...

Eosinophilic esophagitis (EoE) is a rare inflammatory disease of the esophagus, the tube that connects your mouth to your stomach. If you have EoE, a type of white blood cell known as an ...

Roswell Park Comprehensive Cancer Center achieved textbook outcomes for 90% of 150 consecutive robot-assisted, minimally invasive esophagectomies (RAMIE) performed from 2020–2024, as reported in ...